國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Drug delivery for the retina and pos...

Patel, Jayvadan K.

Drug delivery for the retina and posterior segment disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug delivery for the retina and posterior segment diseaseedited by Jayvadan K. Patel ... [et al.].
其他作者:	Patel, Jayvadan K.
出版者:	Cham :Springer International Publishing :2018.
面頁冊數:	xix, 494 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	Ophthalmic drugs.
電子資源:	https://doi.org/10.1007/978-3-319-95807-1
ISBN:	9783319958071$q(electronic bk.)

Drug delivery for the retina and posterior segment disease
Drug delivery for the retina and posterior segment disease[electronic resource] /edited by Jayvadan K. Patel ... [et al.]. - Cham :Springer International Publishing :2018. - xix, 494 p. :ill. (some col.), digital ;24 cm.

Part I- Introduction and basic concept of drug delivery for retina and posterior segment disease -- Anatomy and physiology of retina and posterior segment of the eye -- Pharmacotherapy of diabetic macular edema and retinopathy -- Drug delivery to posterior segment of eye: Conventional delivery strategies, their barriers and restrictions -- Penetration routes to retina and posterior segment -- Diabetic Retinopathy: Pathogenesis, Treatment, and Complications -- PART II-Nanotechnology based formulations for retina and posterior segment disease -- Liposomes for retina and posterior segment disease -- Nano/microparticles for retina and posterior segment disease -- Non-viral delivery systems for gene therapy for retina and posterior segment disease -- Oxidative stress in ocular disorders: Exploring the link to pesticide exposure and potential for using nanotechnology for antioxidant delivery -- Advances in the microbial infection in cornea and role of nanotechnology to cure ocular surface -- Nanomedicine based delivery to the posterior segment of eye: Brighter tomorrow -- Part III-Transscleral iontophoresis for retina and posterior segment disease -- Transscleral drug delivery to retina and posterior segment disease -- Colloidal carrier systems transscleral drug delivery -- Transscleral Iontophoretic Drug Delivery for Treating Retinal Diseases -- Part IV-Implant formulation for posterior eye segment -- Biodegradable polymeric implants for retina and posterior segment disease -- Nanomedicine based gene delivery for the retina and posterior segment diseases -- Part V-Prodrug strategies for retina and posterior segment disease -- Transporter targeted Pro-drug approach for retina and posterior segment disease -- Lipid Prodrug based delivery for retina and posterior segment disease -- Injectable Pro-drugs approach for retina and posterior segment disease -- Stereoisomeric dipeptide Pro-drug approach for retina and posterior segment disease -- Part VI-Other advances for retina and posterior segment diseases -- Receptor targeted Pro-drug approach for retina and posterior segment disease -- Intravitreal injection drug delivery for retina and posterior segment disease: Challenges and Future ahead -- Thermoresponsive gels drug delivery for retina and posterior segment disease -- Peptide synthesis and delivery for retina and posterior segment disease -- Corneal haze, refractive surgery and its implications on choroidal neovascularisation.

This book addresses the issues relating to a wide variety of ocular diseases from which millions of people suffer. Long-term challenges include visual impairment and ocular blindness. Certain ocular diseases are quite rare, whereas others, such as cataracts, age-related macular degeneration (AMD), and glaucoma, are very common, especially in the aging population. A rapid expansion of new technologies in ocular drug delivery and new drug candidates, including biologics, to treat these challenging diseases in the retina and posterior segments of the eye have recently emerged. These approaches are necessary because the eye has many unique barriers to drug delivery. Thus, this timely reference Drug Delivery for the Retina and Posterior Segment Disease compiles and analyzes recent advances in the research and development of drug delivery systems for retina and posterior segment diseases of the eye, with an emphasis on the use of implantable devices, iontophoresis as well as micro- and nanoparticles.

ISBN: 9783319958071$q(electronic bk.)

Standard No.: 10.1007/978-3-319-95807-1doiSubjects--Topical Terms:

302561
Ophthalmic drugs.

LC Class. No.: RE994 / .D784 2018

Dewey Class. No.: 617.7061

Drug delivery for the retina and posterior segment disease
LDR:04486nmm a2200325 a 4500 001 545485
003 DE-He213
005 20190321103532.0
006 m d
007 cr nn 008maaau
008 190530s2018 gw s 0 eng d
020 $a 9783319958071$q(electronic bk.)
020 $a 9783319958064$q(paper)
024 7 $a 10.1007/978-3-319-95807-1 $2 doi
035 $a 978-3-319-95807-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RE994 $b .D784 2018
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 617.7061 $2 23
090 $a RE994 $b .D794 2018
245 0 0 $a Drug delivery for the retina and posterior segment disease $h [electronic resource] / $c edited by Jayvadan K. Patel ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a xix, 494 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I- Introduction and basic concept of drug delivery for retina and posterior segment disease -- Anatomy and physiology of retina and posterior segment of the eye -- Pharmacotherapy of diabetic macular edema and retinopathy -- Drug delivery to posterior segment of eye: Conventional delivery strategies, their barriers and restrictions -- Penetration routes to retina and posterior segment -- Diabetic Retinopathy: Pathogenesis, Treatment, and Complications -- PART II-Nanotechnology based formulations for retina and posterior segment disease -- Liposomes for retina and posterior segment disease -- Nano/microparticles for retina and posterior segment disease -- Non-viral delivery systems for gene therapy for retina and posterior segment disease -- Oxidative stress in ocular disorders: Exploring the link to pesticide exposure and potential for using nanotechnology for antioxidant delivery -- Advances in the microbial infection in cornea and role of nanotechnology to cure ocular surface -- Nanomedicine based delivery to the posterior segment of eye: Brighter tomorrow -- Part III-Transscleral iontophoresis for retina and posterior segment disease -- Transscleral drug delivery to retina and posterior segment disease -- Colloidal carrier systems transscleral drug delivery -- Transscleral Iontophoretic Drug Delivery for Treating Retinal Diseases -- Part IV-Implant formulation for posterior eye segment -- Biodegradable polymeric implants for retina and posterior segment disease -- Nanomedicine based gene delivery for the retina and posterior segment diseases -- Part V-Prodrug strategies for retina and posterior segment disease -- Transporter targeted Pro-drug approach for retina and posterior segment disease -- Lipid Prodrug based delivery for retina and posterior segment disease -- Injectable Pro-drugs approach for retina and posterior segment disease -- Stereoisomeric dipeptide Pro-drug approach for retina and posterior segment disease -- Part VI-Other advances for retina and posterior segment diseases -- Receptor targeted Pro-drug approach for retina and posterior segment disease -- Intravitreal injection drug delivery for retina and posterior segment disease: Challenges and Future ahead -- Thermoresponsive gels drug delivery for retina and posterior segment disease -- Peptide synthesis and delivery for retina and posterior segment disease -- Corneal haze, refractive surgery and its implications on choroidal neovascularisation.
520 $a This book addresses the issues relating to a wide variety of ocular diseases from which millions of people suffer. Long-term challenges include visual impairment and ocular blindness. Certain ocular diseases are quite rare, whereas others, such as cataracts, age-related macular degeneration (AMD), and glaucoma, are very common, especially in the aging population. A rapid expansion of new technologies in ocular drug delivery and new drug candidates, including biologics, to treat these challenging diseases in the retina and posterior segments of the eye have recently emerged. These approaches are necessary because the eye has many unique barriers to drug delivery. Thus, this timely reference Drug Delivery for the Retina and Posterior Segment Disease compiles and analyzes recent advances in the research and development of drug delivery systems for retina and posterior segment diseases of the eye, with an emphasis on the use of implantable devices, iontophoresis as well as micro- and nanoparticles.
650 0 $a Ophthalmic drugs. $3 302561
650 0 $a Drug delivery systems. $3 196465
650 1 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Ophthalmology. $3 274149
700 1 $a Patel, Jayvadan K. $3 824417
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-319-95807-1
950 $a Biomedical and Life Sciences (Springer-11642)